The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis

Low skeletal muscle mass (LSMM) is increasingly recognized for its predictive value for adverse events in cancer patients. In specific, the predictive value of LSMM has been demonstrated for anti-cancer drug toxicity in a variety of cancer types and anti-cancer drugs. However, due to the limited sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Huiskamp, Laura F. J., Chargi, Najiba, Devriese, Lot A., May, Anne M., Huitema, Alwin D. R., de Bree, Remco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700117/
https://www.ncbi.nlm.nih.gov/pubmed/33238530
http://dx.doi.org/10.3390/jcm9113780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700117/
https://www.ncbi.nlm.nih.gov/pubmed/33238530
http://dx.doi.org/10.3390/jcm9113780

Ejemplares similares